“Current Perspective Recent advances in the management of colorectal cancer”; Authors: E. Van Cutsem, M. Dicato, J. Wils; European Journal of Cancer 37; Elsevier Science Ltd.; 2001; pp. 2302-2309. |
Monthly Focus: Central & Peripheral Nervous Systems; “Anti-inflammatory drugs: a hope for Alzheimer's disease?”; Authors: Michael Hull, Klaus Lieb & Bernd L. Fiebich; Asley Publications Ltd.; 2000; pp. 671-683. |
News and Views; “Towards a better aspirin”; Author: John Vane; Nature, vol. 367; Jan. 20, 1994; pp. 215-216. |
Meeting Report; “COX-1 and COX-2: Toward the Development of More Selective NSAIDs”; Authors: Bruno Battistini, Regina Botting and Y.S. Bakble; DN & P7 (8); Oct. 1994; pp. 501-512. |
Chapter 19; “Selective Cycloozygenase Inhibitors”; Authors: David B. Reitz and Karen Seibert; Annual Reports in Medicina Chemistry-30; Academic Press, Inc.; 1995; pp. 179-188. |
Pergamon; “Synthesis and Biological Evaluation of 2,3-Diarylthiophenes as Selective COX-2 and COX-1 Inhibitors”; Authors: Yves Leblanc, Jacques Yves Gauthier, Diane Ethier, Jocelyne Guay, Joseph Mancini, Denis Riendeau, Philip Tagari, Philip Vichers, Elizabeth Wong and Petpiboon Prasit; Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 18; Elsevier Science Ltd.; 1995; pp. 2123-2128. |
“Synthesis and Biological Evaluation of the 1, 5-Diarylpyrazole Class of Cycloozygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H—pyrazol-1-yl] benzenesulfonamide (SC-58635, Celecoxib)”; Authors: Thomas D. Penning, et al.; Journal of Medicinal Chemistry vol. 40, No. 9; American Chemical Society; 1997; pp. 1347-1365. |